Nonalcoholic Steatohepatitis (NASH)

Nonalcoholic Steatohepatitis (NASH) is a severe form of nonalcoholic fatty liver disease (NAFLD) that can progress to liver cirrhosis, liver failure, and even liver cancer. Unlike liver diseases caused by alcohol consumption, NASH occurs in individuals who consume little to no alcohol. It is primarily associated with obesity, diabetes, metabolic syndrome, and high cholesterol. Given the rising prevalence of obesity and metabolic disorders worldwide, NASH is emerging as a significant public health concern.

Understanding NASH

NASH is characterized by the accumulation of fat in the liver along with inflammation and liver cell damage. If left untreated, it can lead to fibrosis (scarring of the liver), cirrhosis, and hepatocellular carcinoma (liver cancer). Many people with NASH remain asymptomatic until the disease progresses to an advanced stage.

Causes and Risk Factors

The exact cause of NASH is not fully understood, but it is linked to multiple metabolic and genetic factors. Common risk factors include:

1. Obesity and Overweight

• Excess fat accumulation in the liver is a primary driver of NASH.
• Visceral fat (fat around internal organs) increases the risk.

2. Type 2 Diabetes and Insulin Resistance

• Insulin resistance plays a key role in fat accumulation and inflammation in the liver.
• People with diabetes have a higher risk of progressing from simple fatty liver (NAFLD) to NASH.

3. Metabolic Syndrome

• A combination of obesity, high blood sugar, high cholesterol, and hypertension increases NASH risk.

4. High Cholesterol and Triglycerides

• Elevated levels of blood lipids contribute to fat buildup in the liver.

5. Genetic and Family History

• Certain genetic mutations, such as PNPLA3, increase susceptibility to NASH.
• A family history of liver disease may indicate a higher risk.

6. Polycystic Ovary Syndrome (PCOS)

• Women with PCOS have higher rates of insulin resistance and obesity, increasing their NASH risk.

7. Sleep Apnea

• Chronic sleep apnea is linked to metabolic dysfunction and liver inflammation.

8. Hypothyroidism and Other Endocrine Disorders

• Low thyroid hormone levels have been associated with fatty liver disease.

Nonalcoholic Steatohepatitis (NASH) symptoms

Most individuals with NASH do not experience symptoms in the early stages. However, as liver damage progresses, the following symptoms may develop:

• Fatigue and Weakness
• Unexplained Weight Loss
• Abdominal Pain (Upper Right Side)
• Jaundice (Yellowing of Skin and Eyes)
• Swelling in Legs and Abdomen (Edema and Ascites)
• Easy Bruising and Bleeding
• Confusion and Memory Issues (Hepatic Encephalopathy in Advanced Stages)

Diagnosis of Nonalcoholic Steatohepatitis (NASH)

Since NASH often remains silent until later stages, routine screenings for individuals at high risk are crucial. The following diagnostic methods help confirm NASH:

1. Blood Tests

• Liver Function Tests (LFTs): Elevated ALT (alanine aminotransferase) and AST (aspartate aminotransferase) levels indicate liver damage.
• Lipid Profile and Blood Sugar Tests to assess metabolic risk factors.

2. Imaging Tests

• Ultrasound: Identifies fatty liver changes but cannot distinguish NASH from simple fatty liver.
• FibroScan (Transient Elastography): Measures liver stiffness, indicating fibrosis.
• MRI or CT Scan: Provides detailed imaging of the liver.

3. Liver Biopsy (Gold Standard for Diagnosis)

• A small liver tissue sample is examined to confirm inflammation, fat accumulation, and fibrosis severity.

Nonalcoholic Steatohepatitis (NASH) treatment

There is no FDA-approved medication specifically for NASH. However, lifestyle modifications and targeted treatments help manage the disease and prevent progression.

1. Lifestyle Changes

a) Weight Loss

• Losing 7-10% of body weight significantly reduces liver fat and inflammation.
• A caloric deficit diet and regular exercise help achieve sustainable weight loss.

b) Healthy Diet

• A Mediterranean diet rich in fruits, vegetables, whole grains, lean proteins, and healthy fats is recommended.
• Avoid processed foods, sugary drinks, and trans fats.

c) Regular Exercise

• 150-300 minutes of moderate-intensity exercise per week improves liver health.
• Resistance training also helps improve insulin sensitivity.

2. Medications (Under Investigation or Off-Label Use)

• Vitamin E: May reduce liver inflammation in non-diabetic NASH patients.
• Pioglitazone: Improves insulin resistance and liver fat content.
• GLP-1 Receptor Agonists (e.g., Semaglutide, Liraglutide): Promising weight loss benefits for NASH patients.
• SGLT2 Inhibitors: May have protective effects on liver metabolism.

3. Managing Underlying Conditions

• Control diabetes, high blood pressure, and high cholesterol.
• Regular monitoring of liver function in at-risk individuals.

4. Liver Transplant (For End-Stage NASH Cirrhosis)

• Patients with severe cirrhosis may require a liver transplant.

Nonalcoholic Steatohepatitis (NASH) prevention

NASH prevention focuses on maintaining a healthy weight and metabolic health. Effective strategies include:

• Regular Exercise: At least 30 minutes per day, five times a week.
• Balanced Diet: Avoid high-calorie, processed foods.
• Regular Health Screenings: Early detection of metabolic disorders.
• Avoid Alcohol and Smoking: These exacerbate liver damage.
• Manage Stress and Sleep Disorders: Poor sleep contributes to metabolic dysfunction.

Nonalcoholic Steatohepatitis (NASH) is a serious liver disease linked to obesity, diabetes, and metabolic disorders. Early detection and lifestyle modifications play a crucial role in managing NASH and preventing complications like cirrhosis and liver failure. While research is ongoing for specific drug treatments, weight loss, diet, and exercise remain the cornerstone of management. Individuals at high risk should undergo regular screenings and seek medical guidance to prevent disease progression.

If you are at risk of NASH, consult a healthcare provider for proper evaluation and preventive strategies.

To consult a Gastroenterologist at Sparsh Diagnostic Centre, call our helpline number 9830117733.

#BhaloTheko 

Disclaimer:

No content on this site, regardless of date, should ever be used as a substitute for direct medical advice from your doctor or other qualified clinician.